ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma

Chen, Zi; Ge, Linyang; Xu, Shuanglan; Li, Qin*; Zhou, Linfu*1
Scientific Reports2023-6-19DOI: 10.1038/s41598-023-36720-1
7阅读
引用收藏
分享

摘要

Lung adenocarcinoma (LUAD) is one of the most common causes of cancer-related death. The role of pyroptosis in LUAD remains unclear. Our study aimed to identify a prognostic signature of pyroptosis-related genes (PRGs) and explore the connection of PRGs with the tumour microenvironment in LUAD. Gene expression and clinical information were obtained from The Cancer Genome Atlas database. Consensus clustering was applied to classify LUAD patients. The least absolute shrinkage and selection operator Cox and multivariate Cox regression models were used to generate a PRG-related prognostic signature. The correlations between PRGs and tumour-infiltrating immune cells or the tumour mutational burden were analysed by Spearman's correlation analysis. In this study, 44 PRGs significantly differed in expression between LUAD and normal tissues. Based on these genes, patients were clustered into three clusters with significantly different distributions of tumour-infiltrating immune cells and immune checkpoint regulators. A total of four PRGs (NLRP1, HMGB1, CYCS, and BAK1) were used to construct a prognostic model. Significant correlations were observed between these prognostic PRGs and immune cell infiltration or the tumour mutational burden. Predictive nomogram results showed that BAK1 could be an independent prognostic biomarker in LUAD. Additionally, the expression level of BAK1 was validated in two independent Gene Expression Omnibus cohorts. Our identified prognostic PRG signature may provide insight for future studies targeting pyroptosis and the tumour microenvironment in LUAD. Future studies are needed to verify our current findings.

学科与关键词

关键词
INFLAMMASOME ACTIVATIONCELL-DEATH
相关
加载中…
  • A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
    Zhu, Kaibin; Yan, An; Zhou, Fucheng; Zhao, Su; Ning, Jinfeng; Yao, Lei; Shang, Desi; Chen, Lantao*Frontiers in Genetics, 2022, 13: 891301.被引 3
  • Identification of a prognostic index system and tumor immune infiltration characterization for lung adenocarcinoma based on mRNA molecular of pyroptosis
    Li, Huawei; Chang, Xiaoyan; Wang, Haiyan; Peng, Bo; Wang, Jun; Zhang, Pengfei; Zhang, Linyou*Frontiers in Medicine, 2022, 9: 934835.
  • Implications of different cell death patterns for prognosis and immunity in lung adenocarcinoma
    Zhou, Yang; Gao, Weitong; Xu, Yu; Wang, Jiale; Wang, Xueying; Shan, Liying; Du, Lijuan; Sun, Qingyu; Li, Hongyan; Liu, Fang*npj Precision Oncology, 2023, 7(1): 121.
查看全部 →

发表信息

论文状态
公开发表
期刊
Scientific Reports
发表日期
2023-06-19
卷期
第 13 卷, 第 1 期
页码
9921
DOI
10.1038/s41598-023-36720-1
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2022YFF0710800, 2018YFC1313600]; Major International (Regional) Joint Research Project of China [81820108001]; National Natural Science Foundation of China [81670029]; Jiangsu Key Principal Investigator of Medicine [ZDRCA2016018]; Jiangsu Provincial Project [333, BRA2019078]; Guangzhou Planned Project of Science and Technology [202102010030]; Guangdong Basic and Applied Basic Research Foundation [2021A1515111105]; Medical Science and Technology Development Foundation; Nanjing Department of Health [YKK20171]

作者

  • C

    Chen, Zi (第一作者)

    1 · nanjing med univ

  • G

    Ge, Linyang

    1 · nanjing med univ

查看全部 5 位作者收起作者
  • X

    Xu, Shuanglan

    1 · nanjing med univ

  • L

    Li, Qin (通讯)

    new · 1

  • Z

    Zhou, Linfu (通讯)

    nanjing med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417